Search Browse Earnings

AGILE THERAPEUTICS INC — SlamSEC

AGILE THERAPEUTICS INC

Pharmaceutical Preparations·PRINCETON, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$4.1M

+447.5% YoY

FY 2023

Adj. EBITDA

-$68.9M

-1681.1% margin

FY 2023

Net Income

-$71.1M

-1732.9% margin

FY 2023

EPS (Diluted)

-$1464.20

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$5.2M

FY 2023

Total Debt

$16.4M

FY 2021

Net Debt

$11.1M

FY 2021

Enterprise Value

—

Debt / EBITDA

-0.2x

FY 2023

EV / EBITDA

—

Employees

—

CFO

Coiante Scott M